Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Maine Propels Cannabis Research Advancements at Brunswick Landing with Maridose Partnership
By: PR Newswire Association LLC. - 30 Jan 2024Back to overview list

BRUNSWICK, Maine, Jan. 29, 2024 /PRNewswire/ -- Maridose, a leading Drug Enforcement Administration (DEA) Licensed Bulk Manufacturer of cannabis for research and a trailblazer in the cannabis industry, proudly announces the establishment of a Center of Excellence for Cannabis Research at Brunswick Landing, Maine. This expansion enhances the company's current location at Brunswick Landing increasing research capabilities and cultivating high-quality, research-grade cannabis for DEA-approved studies, with the ultimate goal of commercializing prescription drugs, non-prescription drugs, and dietary supplements.

Richard Shain, founder and visionary of Maridose, expressed his pride in the ongoing relationship and support from the State of Maine and MRRA, the operator of Brunswick Landing. Shain emphasized, "We are grateful for the continued collaboration with the State of Maine and MRRA, whose support has been instrumental in realizing our vision for advancing cannabis research."

Maridose recognizes the unique advantages of locating at TechPlace, Brunswick Landing's innovation center provides Maridose access to a collaborative environment fostering innovation, cutting-edge technologies, and a network of like-minded professionals. The synergy between Maridose's research endeavors and TechPlace's ecosystem positions the company at the forefront of cannabis research. The parties are convinced Maridose's expertise in developing cannabis-related pharmaceuticals and wellness products will also contribute to the growth of Maine's biotech community and the broader research industry.

Expansion funding for this transformative project is currently underway through a private placement managed by Young America Capital. This collaboration ensures that Maridose's vision for a Center of Excellence for Cannabis Research becomes a reality.

For media inquiries, please contact:

Richard Shain

Richards@maridose.com

About Maridose LLC

Maridose is a leading DEA-licensed biopharmaceutical research and product development company focused on cannabis and cannabis-derived products. The company was selected by the U.S. DOJ and DEA to legally cultivate and sell cannabis. Maridose's Center of Excellence is located in Brunswick Landing, Maine providing best-in-class cannabis cultivation, research and product development.

About TechPlace, Brunswick Landing

TechPlace at Brunswick Landing is an innovation hub fostering collaboration and cutting-edge research. This dynamic ecosystem provides Maridose with state-of-the-art facilities and a vibrant community, positioning the company at the forefront of cannabis research. For more information, visit https://brunswicklanding.us/techplace-maines-technology-incubator/ 

Cision View original content:https://www.prnewswire.com/news-releases/maine-propels-cannabis-research-advancements-at-brunswick-landing-with-maridose-partnership-302047354.html

SOURCE Maridose LLC

Copyright 2024 PR Newswire Association LLC. Back to overview list
to the top ↑